No abstract available
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antiviral Agents / administration & dosage*
-
Comorbidity
-
Drug Therapy, Combination
-
Female
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / epidemiology*
-
Hepatitis C, Chronic / pathology
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage
-
Liver Cirrhosis / epidemiology*
-
Liver Cirrhosis / pathology
-
Male
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Ribavirin / administration & dosage
-
Risk Assessment
-
Severity of Illness Index
-
Survival Rate
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Ribavirin